Evogene Financial Statements From 2010 to 2024
| EVGN Stock | ILA 241.10 15.70 6.11% |
Check Evogene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evogene main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Evogene financial statements analysis is a perfect complement when working with Evogene Valuation or Volatility modules.
Evogene |
Evogene Company Current Valuation Analysis
Evogene's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Evogene Current Valuation | 8.8 M |
Most of Evogene's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evogene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Evogene has a Current Valuation of 8.8 M. This is 99.94% lower than that of the Biotechnology sector and 99.81% lower than that of the Health Care industry. The current valuation for all Israel stocks is 99.95% higher than that of the company.
Evogene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evogene's current stock value. Our valuation model uses many indicators to compare Evogene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evogene competition to find correlations between indicators driving Evogene's intrinsic value. More Info.Evogene is rated # 4 in return on equity category among related companies. It is rated # 4 in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evogene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evogene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evogene's earnings, one of the primary drivers of an investment's value.About Evogene Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evogene income statement, its balance sheet, and the statement of cash flows. Evogene investors use historical funamental indicators, such as Evogene's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evogene investors may use each financial statement separately, they are all related. The changes in Evogene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evogene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evogene Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evogene. Please read more on our technical analysis and fundamental analysis pages.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 131 people.
Pair Trading with Evogene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evogene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Evogene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evogene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evogene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evogene to buy it.
The correlation of Evogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evogene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Evogene Correlation against competitors. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Evogene Stock analysis
When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |